{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:40:19Z","timestamp":1790743219561,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Echocardiogr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12574-017-0340-x","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T12:17:29Z","timestamp":1499084249000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Fabry disease"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2746-3262","authenticated-orcid":false,"given":"Toshinori","family":"Yuasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Horizoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Cyaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitsugu","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kisanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288\u201393.","journal-title":"N Engl J Med"},{"key":"340_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841\u20132.","journal-title":"Circulation"},{"key":"340_CR3","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JP, Austin HA 3rd, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001;285:2743\u20139.","journal-title":"JAMA"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12574-015-0240-x","volume":"13","author":"S Nakatani","year":"2015","unstructured":"Nakatani S, Akaishi M, Asanuma T, et al. Guidelines from the Japanese society of echocardiography: guidance for the management and maintenance of echocardiography equipment. J Echocardiogr. 2015;13:1\u20135.","journal-title":"J Echocardiogr"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jbspin.2003.10.015","volume":"71","author":"C Masson","year":"2004","unstructured":"Masson C, Ciss\u00e9 I, Simon V, et al. Fabry disease: a review. Joint Bone Spine. 2004;71:381\u20133.","journal-title":"Joint Bone Spine"},{"key":"340_CR6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","volume":"40","author":"C Kampmann","year":"2002","unstructured":"Kampmann C, Baehner F, Whybra C, et al. Cardiac manifestations of Anderson\u2013Fabry disease in heterozygous females. J Am Coll Cardiol. 2002;40:1668\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","volume":"110","author":"C Chimenti","year":"2004","unstructured":"Chimenti C, Pieroni M, Morgante E, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004;110:1047\u201353.","journal-title":"Circulation"},{"key":"340_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP57001","volume":"57","author":"RJ Desnick","year":"2002","unstructured":"Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin Nephrol. 2002;57:1\u20138.","journal-title":"Clin Nephrol"},{"key":"340_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","volume":"96","author":"JS Shah","year":"2005","unstructured":"Shah JS, Hughes DA, Sachdev B, et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson\u2013Fabry disease. Am J Cardiol. 2005;96:842\u20136.","journal-title":"Am J Cardiol"},{"key":"340_CR10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Invest. 2004;34:236\u201342.","journal-title":"Eur J Invest"},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","volume":"51","author":"T Takenaka","year":"2008","unstructured":"Takenaka T, Teraguchi H, Yoshida A, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol. 2008;51:50\u20139.","journal-title":"J Cardiol"},{"key":"340_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/hrt.2010.211789","volume":"97","author":"M Namdar","year":"2011","unstructured":"Namdar M, Steffel J, Vidovic M, et al. Electrocardiographic changes in early recognition of Fabry disease. Heart. 2011;97:485\u201390.","journal-title":"Heart"},{"key":"340_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","volume":"111","author":"P Hoign\u00e9","year":"2006","unstructured":"Hoign\u00e9 P, Attenhofer Jost CH, Duru F, et al. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. Int J Cardiol. 2006;111:413\u201322.","journal-title":"Int J Cardiol"},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson\u2013Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407\u201311.","journal-title":"Circulation"},{"key":"340_CR15","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Mar\u00edn F, et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007;50:2399\u2013403.","journal-title":"J Am Coll Cardiol"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp588","volume":"31","author":"JC Wu","year":"2010","unstructured":"Wu JC, Ho CY, Skali H, et al. Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity. Eur Heart J. 2010;31:1088\u201397.","journal-title":"Eur Heart J"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jacc.2013.07.121","volume":"63","author":"JB Geske","year":"2014","unstructured":"Geske JB, Jouni H, Aubry MC, Gersh BJ. Fabry disease with resting outflow obstruction masquerading as hypertrophic cardiomyopathy. J Am Coll Cardiol. 2014;63:e43.","journal-title":"J Am Coll Cardiol"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2005.11.070","volume":"47","author":"M Pieroni","year":"2006","unstructured":"Pieroni M, Chimenti C, DeCobelli F, et al. Fabry\u2019s disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol. 2006;47:1663\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2008.02.046","volume":"51","author":"S Kounas","year":"2008","unstructured":"Kounas S, Demetrescu C, Pantazis AA, et al. The binary endocardial appearance is a poor discriminator of Anderson\u2013Fabry disease from familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2058\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ejechocard\/jer112","volume":"12","author":"G Mundigler","year":"2011","unstructured":"Mundigler G, Gaggl M, Heinze G, et al. The endocardial binary appearance (\u2018binary sign\u2019) is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy. Eur J Echocardiogr. 2011;12:744\u20139.","journal-title":"Eur J Echocardiogr"},{"key":"340_CR21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","volume":"107","author":"M Pieroni","year":"2003","unstructured":"Pieroni M, Chimenti C, Ricci R, et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation. 2003;107:1978\u201384.","journal-title":"Circulation"},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.echo.2013.09.005","volume":"26","author":"M Shanks","year":"2013","unstructured":"Shanks M, Thompson RB, Paterson ID, et al. Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr. 2013;26:1407\u201314.","journal-title":"J Am Soc Echocardiogr"},{"key":"340_CR23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","volume":"4","author":"M Niemann","year":"2011","unstructured":"Niemann M, Herrmann S, Hu K, et al. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011;4:592\u2013601.","journal-title":"JACC Cardiovasc Imaging"},{"key":"340_CR24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.echo.2013.08.024","volume":"26","author":"AC Boyd","year":"2013","unstructured":"Boyd AC, Lo Q, Devine K, et al. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy. J am Soc Echocardiogr. 2013;26:1415\u201323.","journal-title":"J am Soc Echocardiogr"},{"key":"340_CR25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.114.009789","volume":"130","author":"SF Nagueh","year":"2014","unstructured":"Nagueh SF. Anderson\u2013Fabry disease and other lysosomal storage disorders. Circulation. 2014;130:1081\u201390.","journal-title":"Circulation"},{"key":"340_CR26","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1136\/hrt.2010.204586","volume":"96","author":"M Nieman","year":"2010","unstructured":"Nieman M, Breunig F, Beer M, et al. The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy. Heart. 2010;96:1915\u20139.","journal-title":"Heart"},{"key":"340_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2006.07.088","volume":"99","author":"M Kawano","year":"2007","unstructured":"Kawano M, Takenaka T, Otsuji Y, et al. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry\u2019s disease. Am J Cardiol. 2007;99:261\u20133.","journal-title":"Am J Cardiol"},{"issue":"1","key":"340_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345(1):9\u201316.","journal-title":"N Engl J Med"},{"key":"340_CR29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann Breunig F, et al. Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119:524\u20139.","journal-title":"Circulation"},{"key":"340_CR30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F Weidemann","year":"2003","unstructured":"Weidemann F, Breunig F, Beer M, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation. 2003;108:1299\u2013301.","journal-title":"Circulation"}],"container-title":["Journal of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12574-017-0340-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-017-0340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-017-0340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T12:44:51Z","timestamp":1509972291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12574-017-0340-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s12574-017-0340-x","relation":{},"ISSN":["1349-0222","1880-344X"],"issn-type":[{"value":"1349-0222","type":"print"},{"value":"1880-344X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]}}}